Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by JDavenporton Dec 14, 2020 1:59pm
352 Views
Post# 32101159

24-hour CEO

24-hour CEOWhile listening in on the AGM webcast last week I noticed on my world clock (it's always on one of my monitors) that the meeting started after midnight in Adelaide, Australia. It was over at 01:30 AM for DrDR.

I've talked to DrDR before about the hours she keeps, talking to the North American and European pharmaceutical industry executives at really weird hours in Australia. In the summer, Adelaide is 17.5 hours ahead of Pacific Daylight Savings Time. It's 18.5 hours ahead of me in the winter, currently 15.5 hours ahead of the east coast (EST). And she's 10.5 hours ahead of London, UK.

I'm getting a little cranky over those who think she works part time. Midday in Australia happens when the East Coast of NA and Europe are sleeping or about to sleep and while the West Coast of NA is shutting down.

DrDR's business hours are horrible, but I would contend that during Adelaide's midday hours DrDR is free from almost all connections that relate to Bioasis. In other words, in Adelaide, she's free during her mid-day hours to surf, swim, read a book, run Carina Biotech or to do anything else she wants to get her jollies.

This "part-time" stuff is nonsense, as I believe you will soon see. She needs the support of shareholders because you can be assured that efforts to run her down here on SH or anywhere else are noticed by partners and potential partners. They all follow SH and they have a financial interest in putting pressure on Bioasis if they think for a moment that the BoD and executive do not have the full support of shareholders.

She's closer to a 24-hour CEO than to a part time CEO and it's time for a few people here and in my world to stop the nonsense about it.

jd


<< Previous
Bullboard Posts
Next >>